Filing Details
- Accession Number:
- 0001179110-12-009720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-06 16:55:23
- Reporting Period:
- 2012-06-04
- Filing Date:
- 2012-06-06
- Accepted Time:
- 2012-06-06 16:55:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1347405 | Robert Bowen | C/O Abiomed, Inc 22 Cherry Hill Dr Danvers MA 01923 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Disposition | 2012-06-04 | 3,351 | $19.30 | 64,921 | No | 4 | F | Direct | |
| Common Stock, $.01 Par | Acquisiton | 2012-06-04 | 14,000 | $0.00 | 78,921 | No | 4 | A | Direct | |
| Common Stock , $.01 Par Value | Disposition | 2012-06-05 | 7,316 | $20.00 | 71,605 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $15.92 | 2009-12-22 | 2018-12-22 | 100,000 | 100,000 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 60,000 | 60,000 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-03-31 | 2019-05-28 | 30,000 | 30,000 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 30,000 | 30,000 | Direct |
| Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-12-22 | 100,000 | 100,000 | Direct |
| 2019-05-28 | 60,000 | 60,000 | Direct |
| 2019-05-28 | 30,000 | 30,000 | Direct |
| 2020-06-03 | 30,000 | 30,000 | Direct |
| 2022-05-22 | 20,000 | 20,000 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10(b)5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $19.2200 and $19.7500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- These restricted stock units will vest in 50% increments, the first 50% on May 26, 2013 and the remaining 50% on May 26, 2014.
Billionaire Hedge Funds
